Council of Europe: Appendix A of the European convention for the protection of vertebrate animals used for experimental and other scientific purposes (ETS 494 no. 123) – Guidelines for the accommodation and care of animals (Article 5 of the Convention), Council of Europe, Strasbourg, France, ETS No. 123 (2006), effective from 15 July 2007. 

ICH M3(R2): Guidance on nonclinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals, available at: https://database.ich.org/sites/default/files/M3_R2_Guideline.pdf (last access: 3 March 2020), 2009. 

ICH S6(R1): Preclinical safety evaluation of biotechnology-derived pharmaceuticals, available at: https://database.ich.org/sites/default/files/S6_R1_Guideline_0.pdf (last access: 3 March 2020), 2011. 

Jarvis, P., Srivastav, S., Vogelwedde, E., Stewart, J., Mitchard, T., and Weinbauer, G. F.: The cynomolgus monkey as a model for developmental toxicity studies: variability of pregnancy losses, statistical power estimates and group size considerations, Birth Defects Res. B, 89, 175–187, 2010.  

Krejsa, M., Neradilek, M. B., Polissar, N. L., Cox, N., Clark, D., Cowan, L., Bussiere, J., and Lebrec, H.: An inter-laboratory retrospective analysis of immunotoxicological endpoints in non-human primates: Flow cytometry immunophenotyping, J. Immunotoxicol., 10, 361–372, 2013.